Premium
Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin
Author(s) -
Bakar Ö,
Demircay Z,
Toker E,
Çakır S
Publication year - 2009
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2009.03132.x
Subject(s) - medicine , papulopustular , azithromycin , rosacea , dermatology , hyperaemia , population , ophthalmology , antibiotics , blood flow , environmental health , microbiology and biotechnology , acne , biology
Background Tetracycline derivatives provide moderate benefit in the treatment of ocular rosacea. Recently, azithromycin has been found to be an effective alternative in the treatment of cutaneous papulopustular rosacea. Objective We planned a study to evaluate the effects of azithromycin on ocular symptoms, signs and tear function tests of papulopustular rosacea patients. Methods An open‐labelled study was performed in a population of 20 papulopustular rosacea patients. Results Eighteen subjects completed the trial. Significant improvement was seen in ocular symptoms, eyelid findings and conjunctival hyperaemia scores ( P = 0.002, P < 0.0001, and P = 0.005, respectively). Therapeutic benefit was not observed in ocular surface staining scores. Baseline values of Schirmer test results were within normal limits. No significant side‐effects were observed. Limitations The study population is limited to dermatology patients who had been referred to the ophthalmology clinic. Conclusion Azithromycin may be a new promising therapeutic alternative in ocular rosacea. Conflicts of interest None declared.